AMTI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Dec 2023 @ 15:59):

Stats
Today's Volume	235 210
Average Volume	320 195
Market Cap	11.01M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.139
ATR14	$0.0200 (7.60%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-27	Epiq Capital Group, Llc	Sell	2 149 292	Common Stock
2023-12-27	Epiq Capital Group, Llc	Sell	3 394 948	Common Stock
2023-12-27	Epiq Capital Group, Llc	Sell	2 500 000	Common Stock
2023-12-27	Epiq Capital Group, Llc	Sell	293 278	Common Stock
2023-12-27	Vandevender Aaron	Sell	212 659	Common Stock

INSIDER POWER
-67.93
Last 100 transactions
Buy: 3 477 833 \| Sell: 13 394 035

Volume Correlation

Long: 0.02 (neutral)

Short: 0.79 (moderate)

Signal:(62.898) Neutral

Applied Molecular Correlation

10 Most Positive Correlations
WOOF	0.969
WKEY	0.967
JAN	0.961
NMRD	0.96
MTLS	0.958
PODD	0.957
QRTEA	0.956
STIM	0.956
GERN	0.955
ENNV	0.955

10 Most Negative Correlations
IGTA	-0.965
NVCN	-0.953
OHAA	-0.952
LCA	-0.951
TIOA	-0.949
BRIVU	-0.949
FTII	-0.949
HDSN	-0.948
MSDA	-0.946
CBRG	-0.941

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Applied Molecular Correlation - Currency/Commodity

0.71
( moderate )

0.80
( moderate )

0.00
( neutral )

0.14
( neutral )

0.33
( neutral )

-0.73
( moderate negative )

Applied Molecular Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.23

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.170

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.440

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.680

Financial Reports:

No articles found.

Applied Molecular

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.